National Institute of Allergy and Infectious Diseases
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Female sex is associated with superior outcomes in patients treated with CD19-directed CAR T-cell therapy for large B-cell lymphoma
Muhammad Bilal Abid, Mumtaz Yaseen, Shahrukh Hashmi, John Behman et al.
Journal
Haematologica
Topics
CAR-T cell therapy research
article
Female sex is associated with superior outcomes in patients treated with CD19-directed CAR T-cell therapy for large B-cell lymphoma
Muhammad Bilal Abid, Mumtaz Yaseen, Shahrukh Hashmi, John Behman, Farrukh Awan, Nausheen Ahmed, Sairah Ahmed, Mohamed A. Kharfan-Dabaja, Mahmoud Aljurf, Praveen Ramakishnan
article en
Abstract
No abstract available for this paper.
Publication Tag
Haematologica
Institutions
Texas Tech University (US), The University of Texas MD Anderson Cancer Center (US), Duke University (US), King Faisal Specialist Hospital & Research Centre (SA), Southwestern Medical Center (US), Mayo Clinic in Arizona (US), University of Kansas Medical Center (US), Mayo Clinic in Florida (US), Southwestern Medical Center (US), The University of Texas Southwestern Medical Center (US), Texas Tech University Health Sciences Center (US)
Funders
Bristol-Myers Squibb, AstraZeneca, Gilead Sciences, Regeneron Pharmaceuticals, Actinium Pharmaceuticals, MEI Pharma, Adaptive Biotechnologies, BeiGene, Incyte, Cardinal Health, Swedish Orphan Biovitrum, Ipsen, Health Resources and Services Administration, Genentech, Pharmacyclics, Loxo Oncology, National Heart, Lung, and Blood Institute, National Cancer Institute, National Institute of Allergy and Infectious Diseases